Neurological disorders are a wide range of disorders due to structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves. Neurological disorders are often chronic and progressive, affecting all age groups; for example Multiple Sclerosis with typical onset in young adult life and Parkinson's or Alzheimer's diseases which are more common in the elderly. While effective, convenient, and tolerable pharmacological treatments are still lacking for some of neurological disorders, several new drugs are introduced during recent years. However, long-term effect and possible side-effects of the new treatments are not completely known.
At CPE there are a number of ongoing national and international collaborative projects in the field of “Drugs and Neurological disorders”. One example of our international studies in this field is investigating association between exposure to drugs used for treatment of Multiple Sclerosis and adverse pregnancy outcomes. Other important area in which CPE is involved includes pharmacological treatments for attention deficit hyperactivity disorder (ADHD) as a neuropsychiatric disorder.
The research area is led by Shahram Bahmanyar (Publications on PubMed)